Idexx Laboratories Inc IDXX
$550.96
-2.82%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (5 Buy · 3 Hold · 0 Sell)
- Average Price Target
- $731.88
- Implied Upside
- +32.8%
- Price Target Range
- $670.00 – $805.00
- Analysts (12 mo)
- 8
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-11 | BarclaysGlen Santangelo |
Maintains | Overweight | $800 → $710 |
| 2026-08-05 | UBSAndrea Alfonso |
Maintains | Neutral | $620 → $670 |
| 2026-08-05 | CitigroupDaniel Grosslight |
Maintains | Neutral | $650 → $670 |
| 2026-07-27 | UBSAndrea Alfonso |
Maintains | Neutral | $640 → $620 |
| 2026-04-28 | UBSAndrea Alfonso |
Maintains | Neutral | $730 → $640 |
| 2026-04-15 | CitigroupDaniel Grosslight |
Initiates coverage on | Neutral | $650 |
| 2026-03-31 | StifelJonathan Block |
Maintains | Buy | $775 → $675 |
| 2026-02-09 | Piper SandlerDavid Westenberg |
Maintains | Neutral | $775 → $750 |
| 2026-02-05 | BarclaysGlen Santangelo |
Maintains | Overweight | $850 → $800 |
| 2026-02-03 | UBSAndrea Alfonso |
Maintains | Neutral | $750 → $730 |
| 2026-02-03 | BTIGMark Massaro |
Maintains | Buy | $830 → $800 |
| 2025-12-09 | BarclaysGlen Santangelo |
Initiates coverage on | Overweight | $850 |
| 2025-11-04 | Morgan StanleyErin Wright |
Maintains | Overweight | $765 → $805 |
| 2025-11-04 | UBSAndrea Alfonso |
Maintains | Neutral | $710 → $750 |
| 2025-11-04 | JP MorganChris Schott |
Maintains | Overweight | $675 → $775 |
| 2025-11-04 | BTIGMark Massaro |
Maintains | Buy | $785 → $830 |
| 2025-10-31 | StifelJonathan Block |
Upgrades | Hold → Buy | $640 → $700 |
| 2025-10-01 | UBSAndrea Alfonso |
Initiates coverage on | Neutral | $720 |
| 2025-08-15 | Morgan StanleyErin Wright |
Maintains | Overweight | $722 → $765 |
| 2025-08-11 | Piper SandlerDavid Westenberg |
Maintains | Neutral | $510 → $700 |
| 2025-08-04 | JP MorganChris Schott |
Maintains | Overweight | $550 → $675 |
| 2025-07-17 | Leerink PartnersDaniel Clark |
Maintains | Outperform | $580 → $600 |
| 2025-07-02 | StifelJonathan Block |
Maintains | Hold | $510 → $540 |
| 2025-06-11 | Leerink PartnersDaniel Clark |
Maintains | Outperform | $515 → $580 |
| 2025-05-19 | StifelJonathan Block |
Maintains | Hold | $460 → $510 |
| 2025-05-05 | Morgan StanleyErin Wright |
Maintains | Overweight | $548 → $558 |
| 2025-04-14 | StifelJonathan Block |
Maintains | Hold | $450 → $420 |
| 2025-02-10 | Piper SandlerDavid Westenberg |
Maintains | Neutral | $435 → $510 |
| 2025-02-04 | BarclaysBalaji Prasad |
Maintains | Overweight | $481 → $520 |
| 2025-02-04 | B of A SecuritiesMichael Ryskin |
Maintains | Neutral | $475 → $535 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $550.96
- Market Cap
- $44.95 billion
- 52-Week Range
- $506.91 – $769.98
- Average Volume
- 637K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.